Historically, CD8+ T cell–mediated killing is thought to occur predominantly via the perforin-granzyme B pathway, whereas CD4+ T cell–mediated killing is thought to rely on activation of the death receptor Fas on tumor cells by Fas ligand expressed on T cells (Shresta et al, 1998). The gene discussed is CD8A; the disease is neoplasm.